News & Events

NF1 treatment breakthrough
A commonly available nutritional supplement has inspired 11-year-old William Aberley’s self-confidence as he takes part in sports, both in and outside of school. This might seem ordinary, but not for William, who was diagnosed with Neurofibromatosis type 1 (NF1) as a toddler. NF1 is a hereditary genetic disorder affecting about 1 in 3,000 children worldwide. It’s commonly characterised by...
Read more
Research
Congratulations to Associate Professor Aaron Schindeler, who has been awarded a Drug Discovery Initiative grant from the US Children’s Tumor Foundation.  The project will investigate treatments for muscle weakness and fatigue associated with the genetic disease Neurofibromatosis type 1 (NF1), to help children suffering from the condition.    NF1 is one of the most common ge...
Read more